Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Amyloidosis Before Aortic Valve Elective Replacement (SAVER)

NCT04869631 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT04869631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04869631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Amyloidosis Before Aortic Valve Elective Replacement (SAVER)
Lead sponsor
Charite University, Berlin, Germany
Phase
Observational
Overall status
Active, not recruiting
Start date
February 1, 2021
Completion date
March 31, 2028
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, aortic valve stenosis